A ribonucleoprotein-based decaplex CRISPR/Cas9 knockout strategy for CHO host engineering

Joseph Carver1, Marie Kern1, Peggy Ko1

  • 1Cell Culture and Bioprocess Operations, Genentech, Inc., South San Francisco, California, USA.

Biotechnology Progress
|September 19, 2021
PubMed